Dr. Rui Wang, is an Associate Researcher at Shenzhen Bay Laboratory (SZBL). She obtained her Ph.D. from the Chinese University of Hong Kong and performed her postdoctoral joint training at the Southern University of Science and Technology (SUSTech) and the Western University (UWO) in Canada, and continued her training in the CityU of Hong Kong. In 2020, she joined Pingshan translational medicine center, SZBL to start her works in the chemoproteomic filed. She has focused on the cationic salt-based residue-specific chemoproteomic tools to characterize the tunable-reactive warheads and the cellular mechanisms of cancers for post-translational modifications. (Up to 100 words)